NCT02458014: Blinatumomab in Treating Patients With B-cell Acute Lymphoblastic Leukemia With Minimal Residual Disease
- State
- Completed
- Phase
- Phase 2
- People
- 37 taking part
- Started
- 14 Sep 2015
- Primary completion
- 16 Sep 2025
- Arms
- Treatment (blinatumomab + TKI)
- Results
- Posted on the registry
- 29 May 2015: Trial registered
- 14 Sep 2015: Trial started
- 16 Sep 2025: Trial completed
- 25 Sep 2026: Trial results posted